News

CMN Weekly (15 October 2021)

Some of the best links we picked up around the internet

By: Gorm Palmgren - Oct. 15, 2021
News

Top picks

Research

Industry

Clinical News

COVID-19

Reviews

Opinion

  • Future Medicine brings an interview with Geoff MacKay, who talks about new gene therapies for rare diseases. MacKay is the CEO of AVROBIO, a clinical-stage lentiviral gene therapy company that treats lysosomal disorders, and a board member of Talaris Therapeutics and Satellos Bioscience.

Tags

HashtagArticleHashtagMissing linksHashtagNewsHashtagCMN WeeklyHashtagAllogene Therapeutics, Inc.HashtagCRISPR Therapeutics AGHashtagIntellia Therapeutics, Inc.HashtagPoseida TherapeuticsHashtagPrecision BioSciences, Inc.HashtagSarepta Therapeutics

CLINICAL TRIALS
Ovarian Cancer, OC, (NCT06846424)
Sponsors:
Shanghai Gynecologic Oncology Group
Indicator
IND Enabling
Phase I
Phase II
Phase III
Malaria Infection, (NCT06881732)
Sponsors:
University of Melbourne  
Indicator
IND Enabling
Phase I
Phase II
Phase III
Liver Transplant, (NCT07053488)
Sponsors:
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC  
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine